Pharmstandard International S.A., 10% Owner at ARGOS THERAPEUTICS INC (ARGS), bought 75,474 shares at $4.23 ($320K) on 2016-08-19, disclosed to the SEC on 2016-08-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.23 | 53,524 | $226K | 70.8% |
| 2 | $4.26 | 21,950 | $94K | 29.2% |
| Total | $4.24 avg | 75,474 | $320K | 100% |
| Filing → |
| ARGS | BUY | 2016-09-07 | $162K | — | Filing → |
| ARGS | BUY | 2016-08-29 | $252K | — | Filing → |
| ARGS | BUY | 2016-08-25 | $305K | — | Filing → |